ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,651,779 | -75.1% | 79,260 | -71.4% | 0.01% | -75.0% |
| Q2 2023 | $6,638,845 | -47.9% | 277,196 | -59.0% | 0.02% | -55.6% |
| Q1 2023 | $12,737,225 | -16.3% | 676,792 | -29.2% | 0.04% | -18.2% |
| Q4 2022 | $15,214,553 | +3914.4% | 955,688 | +4022.0% | 0.06% | +2650.0% |
| Q3 2022 | $379,000 | -19.4% | 23,185 | +19.3% | 0.00% | 0.0% |
| Q1 2022 | $470,000 | -82.5% | 19,436 | -61.2% | 0.00% | -83.3% |
| Q4 2020 | $2,680,000 | +9.7% | 50,129 | -15.4% | 0.01% | +20.0% |
| Q3 2020 | $2,444,000 | -56.3% | 59,260 | -48.7% | 0.01% | -64.3% |
| Q2 2020 | $5,594,000 | +167.0% | 115,420 | +132.8% | 0.03% | +100.0% |
| Q1 2020 | $2,095,000 | -43.9% | 49,585 | -43.2% | 0.01% | +16.7% |
| Q4 2019 | $3,735,000 | +188.6% | 87,317 | +81.1% | 0.01% | +140.0% |
| Q1 2019 | $1,294,000 | +60.5% | 48,215 | -3.3% | 0.01% | +25.0% |
| Q4 2018 | $806,000 | +467.6% | 49,861 | +689.7% | 0.00% | +300.0% |
| Q1 2018 | $142,000 | – | 6,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |